NVCR logo

NovoCure Limited (NVCR) Return On Equity

Annual ROE

-46.67%
+4.85%+9.41%

December 31, 2024


Summary


Performance

NVCR ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVCRprofitabilitymetrics:

Quarterly ROE

-46.72%
-5.98%-14.68%

December 31, 2024


Summary


Performance

NVCR Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNVCRprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

NVCR ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.4%0.0%
3 y3 years-254.6%-231.3%
5 y5 years-965.5%-940.5%

NVCR ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-254.6%+9.4%-231.3%+7.7%
5 y5-year-917.3%+9.4%-697.4%+7.7%
alltimeall time-917.3%+30.4%-697.4%+44.3%

NovoCure Limited ROE History

DateAnnualQuarterly
Dec 2024
-46.67%(-9.4%)
-46.72%(+14.7%)
Sep 2024
-
-40.74%(-8.6%)
Jun 2024
-
-44.56%(-9.2%)
Mar 2024
-
-49.08%(-3.0%)
Dec 2023
-51.52%(+137.1%)
-50.62%(+9.2%)
Sep 2023
-
-46.35%(+15.7%)
Jun 2023
-
-40.06%(+24.8%)
Mar 2023
-
-32.09%(+50.8%)
Dec 2022
-21.73%(+65.1%)
-21.28%(+11.8%)
Sep 2022
-
-19.03%(+17.0%)
Jun 2022
-
-16.26%(+12.1%)
Mar 2022
-
-14.51%(+2.9%)
Dec 2021
-13.16%(-330.5%)
-14.10%(+105.5%)
Sep 2021
-
-6.86%(+448.8%)
Jun 2021
-
-1.25%(-135.5%)
Mar 2021
-
3.52%(-46.3%)
Dec 2020
5.71%(-230.4%)
6.55%(-16.2%)
Sep 2020
-
7.82%(+42.7%)
Jun 2020
-
5.48%(+15.6%)
Mar 2020
-
4.74%(-205.6%)
Dec 2019
-4.38%
-4.49%(-76.7%)
DateAnnualQuarterly
Sep 2019
-
-19.29%(-40.9%)
Jun 2019
-
-32.62%(-32.2%)
Mar 2019
-
-48.08%(-15.4%)
Dec 2018
-56.29%(+16.8%)
-56.85%(+8.8%)
Sep 2018
-
-52.25%(+0.8%)
Jun 2018
-
-51.84%(-6.1%)
Mar 2018
-
-55.20%(+10.8%)
Dec 2017
-48.19%(-28.1%)
-49.80%(-9.3%)
Sep 2017
-
-54.91%(-15.2%)
Jun 2017
-
-64.75%(-5.4%)
Mar 2017
-
-68.41%(-0.5%)
Dec 2016
-67.07%(+4.8%)
-68.78%(-9.6%)
Sep 2016
-
-76.07%(+4.1%)
Jun 2016
-
-73.10%(-1.4%)
Mar 2016
-
-74.13%(+2.0%)
Dec 2015
-64.00%(+7.0%)
-72.66%(-13.3%)
Sep 2015
-
-83.85%(+8.2%)
Jun 2015
-
-77.52%(+17.6%)
Mar 2015
-
-65.91%(+56.4%)
Dec 2014
-59.84%(+32.9%)
-42.13%
Dec 2013
-45.04%
-

FAQ

  • What is NovoCure Limited annual return on equity?
  • What is the all time high annual ROE for NovoCure Limited?
  • What is NovoCure Limited annual ROE year-on-year change?
  • What is NovoCure Limited quarterly return on equity?
  • What is the all time high quarterly ROE for NovoCure Limited?
  • What is NovoCure Limited quarterly ROE year-on-year change?

What is NovoCure Limited annual return on equity?

The current annual ROE of NVCR is -46.67%

What is the all time high annual ROE for NovoCure Limited?

NovoCure Limited all-time high annual return on equity is 5.71%

What is NovoCure Limited annual ROE year-on-year change?

Over the past year, NVCR annual return on equity has changed by +4.85% (+9.41%)

What is NovoCure Limited quarterly return on equity?

The current quarterly ROE of NVCR is -46.72%

What is the all time high quarterly ROE for NovoCure Limited?

NovoCure Limited all-time high quarterly return on equity is 7.82%

What is NovoCure Limited quarterly ROE year-on-year change?

Over the past year, NVCR quarterly return on equity has changed by 0.00% (0.00%)